{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:53:30Z","timestamp":1791446010911,"version":"4.3.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/cgt.2016.57","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T06:21:24Z","timestamp":1479450084000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells"],"prefix":"10.1038","volume":"23","author":[{"given":"N-Y","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,18]]},"reference":[{"key":"BFcgt201657_CR1","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/1097-0142(19801001)46:7<1650::AID-CNCR2820460726>3.0.CO;2-Y","volume":"46","author":"AD McDonald","year":"1980","unstructured":"McDonald AD, McDonald JC . Malignant mesothelioma in north America. Cancer 1980; 46: 1650\u20131656.","journal-title":"Cancer"},{"key":"BFcgt201657_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA . Malignant mesothelioma. Lancet 2005; 366: 397\u2013408.","journal-title":"Lancet"},{"key":"BFcgt201657_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","volume":"70","author":"GH Eltabbakh","year":"1999","unstructured":"Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME . Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999; 70: 6\u201312.","journal-title":"J Surg Oncol"},{"key":"BFcgt201657_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/sonc.2002.30227","volume":"29","author":"M Carbone","year":"2002","unstructured":"Carbone M, Kratzke RA, Testa JR . The pathogenesis of mesothelioma. Semin Oncol 2002; 29: 2\u201317.","journal-title":"Semin Oncol"},{"key":"BFcgt201657_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.lungcan.2004.08.003","volume":"47","author":"JA Tsou","year":"2005","unstructured":"Tsou JA, Shen LY, Siegmund KD, Long TI, Laird PW, Seneviratne CK et al. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer 2005; 47: 193\u2013204.","journal-title":"Lung Cancer"},{"issue":"7 Supplement","key":"BFcgt201657_CR6","first-page":"2071s","volume":"52","author":"E Wainfan","year":"1992","unstructured":"Wainfan E, Poirier LA . Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 1992; 52 (7 Supplement): 2071s\u20132077s.","journal-title":"Cancer Res"},{"key":"BFcgt201657_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jmg.38.5.285","volume":"38","author":"JF Costello","year":"2001","unstructured":"Costello JF, Plass C . Methylation matters. J Med Genet 2001; 38: 285\u2013303.","journal-title":"J Med Genet"},{"key":"BFcgt201657_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.lungcan.2007.06.015","volume":"58","author":"JA Tsou","year":"2007","unstructured":"Tsou JA, Galler JS, Wali A, Ye W, Siegmund KD, Groshen S et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung cancer 2007; 58: 220\u2013230.","journal-title":"Lung cancer"},{"key":"BFcgt201657_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","volume":"54","author":"JR Fischer","year":"2006","unstructured":"Fischer JR, Ohnmacht U, Rieger N, Zemaitis M, Stoffregen C, Kostrzewa M et al. Promoter methylation of RASSF1A, RAR\u03b2 and DAPK predict poor prognosis of patients with malignant mesothelioma. Lung Cancer 2006; 54: 109\u2013116.","journal-title":"Lung Cancer"},{"key":"BFcgt201657_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd1698","volume":"4","author":"J-PJ Issa","year":"2005","unstructured":"Issa J-PJ, Kantarjian HM, Kirkpatrick P . Azacitidine. Nat Rev Drug Discov 2005; 4: 275\u2013276.","journal-title":"Nat Rev Drug Discov"},{"key":"BFcgt201657_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.lungcan.2010.04.020","volume":"70","author":"K Kai","year":"2010","unstructured":"Kai K, D\u2019Costa S, Yoon B-I, Brody AR, Sills RC, Kim Y . Characterization of side population cells in human malignant mesothelioma cell lines. Lung Cancer 2010; 70: 146\u2013151.","journal-title":"Lung Cancer"},{"key":"BFcgt201657_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/cgt.2015.31","volume":"22","author":"H Kim","year":"2015","unstructured":"Kim H, Kim M, Kim N, Kim Y . Inhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines. Cancer Gene Ther 2015; 22: 387\u2013395.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201657_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods 2001; 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFcgt201657_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2164-15-12","volume":"15","author":"J Su","year":"2014","unstructured":"Su J, Wang Y, Xing X, Liu J, Zhang Y . Genome-wide analysis of DNA methylation in bovine placentas. BMC Genomics 2014; 15: 12.","journal-title":"BMC Genomics"},{"key":"BFcgt201657_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-59745-522-0_5","volume":"507","author":"F Mohn","year":"2009","unstructured":"Mohn F, Weber M, Sch\u00fcbeler D, Roloff T-C . Methylated DNA immunoprecipitation (MeDIP). Methods Mol Biol 2009; 507: 55\u201364.","journal-title":"Methods Mol Biol"},{"key":"BFcgt201657_CR16","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.7150\/jca.15423","volume":"7","author":"M-C Kim","year":"2016","unstructured":"Kim M-C, Kim N-Y, Seo Y-R, Kim Y . An integrated analysis of the genome-wide profiles of dna methylation and mRNA expression defining the side population of a human malignant mesothelioma cell line. J Cancer 2016; 7: 1668\u20131679.","journal-title":"J Cancer"},{"key":"BFcgt201657_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C . A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immuol Methods 1995; 184: 39\u201351.","journal-title":"J Immuol Methods"},{"key":"BFcgt201657_CR18","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-05-0592","volume":"65","author":"L Patrawala","year":"2005","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG . Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2\u2212 cancer cells are similarly tumorigenic. Cancer Res 2005; 65: 6207\u20136219.","journal-title":"Cancer Res"},{"key":"BFcgt201657_CR19","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","volume":"67","author":"MM Ho","year":"2007","unstructured":"Ho MM, Ng AV, Lam S, Hung JY . Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827\u20134833.","journal-title":"Cancer Res"},{"key":"BFcgt201657_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2144\/000112708","volume":"44","author":"FV Jacinto","year":"2008","unstructured":"Jacinto FV, Ballestar E, Esteller M . Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome. Biotechniques 2008; 44: 35.","journal-title":"Biotechniques"},{"key":"BFcgt201657_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4161\/epi.6.1.13313","volume":"6","author":"SS Nair","year":"2011","unstructured":"Nair SS, Coolen MW, Stirzaker C, Song JZ, Statham AL, Strbenac D et al. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 2011; 6: 34\u201344.","journal-title":"Epigenetics"},{"key":"BFcgt201657_CR22","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ncponc0354","volume":"2","author":"SB Baylin","year":"2005","unstructured":"Baylin SB . DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005; 2: S4\u2013S11.","journal-title":"Nat Clin Pract Oncol"},{"key":"BFcgt201657_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V","volume":"183","author":"RL Momparler","year":"2000","unstructured":"Momparler RL, Bovenzi V . DNA methylation and cancer. J Cell Physiol 2000; 183: 145\u2013154.","journal-title":"J Cell Physiol"},{"key":"BFcgt201657_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cell.2015.08.005","volume":"162","author":"JD Licht","year":"2015","unstructured":"Licht JD . DNA methylation inhibitors in cancer therapy: the immunity dimension. Cell 2015; 162: 938\u2013939.","journal-title":"Cell"},{"key":"BFcgt201657_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1124\/jpet.104.074195","volume":"312","author":"R Schneider-Stock","year":"2005","unstructured":"Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R et al. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45-and p53-dependent mechanisms. J Pharmacol Exp Ther 2005; 312: 525\u2013536.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFcgt201657_CR26","volume-title":"Malignant Mesothelioma: Pathogenesis, Diagnosis, and Translational Therapies","author":"HI Pass","year":"2006","unstructured":"Pass HI, Vogelzang N, Carbone M . Malignant Mesothelioma: Pathogenesis, Diagnosis, and Translational Therapies. Springer Science & Business Media: Berlin, 2006."},{"key":"BFcgt201657_CR27","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1038\/onc.2012.469","volume":"32","author":"E Lainey","year":"2013","unstructured":"Lainey E, Wolfromm A, Marie N, Enot D, Scoazec M, Bouteloup C et al. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene 2013; 32: 4331\u20134342.","journal-title":"Oncogene"},{"key":"BFcgt201657_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1590\/1414-431x20144102","volume":"48","author":"X Zhou","year":"2015","unstructured":"Zhou X, Huang S, Zhang D, Zhang S, Li W, Chen Z et al. Effects of 5-aza-2\u2032 deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma. Braz J Med Biol Res 2015; 48: 254\u2013260.","journal-title":"Braz J Med Biol Res"},{"key":"BFcgt201657_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jcp.21089","volume":"213","author":"CY Cho","year":"2007","unstructured":"Cho CY, Wang JH, Chang HC, Chang CK, Hung WC . Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. J Cell Physiol 2007; 213: 65\u201369.","journal-title":"J Cell Physiol"},{"key":"BFcgt201657_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.trecan.2016.04.002","volume":"2","author":"RA Burrell","year":"2016","unstructured":"Burrell RA, Swanton C . Re-evaluating clonal dominance in cancer evolution. Trends Cancer 2016; 2: 263\u2013276.","journal-title":"Trends Cancer"},{"key":"BFcgt201657_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00428-003-0902-3","volume":"444","author":"L Pylkk\u00e4nen","year":"2004","unstructured":"Pylkk\u00e4nen L, Wolff H, Stjernvall T, Knuuttila A, Anttila S, Husgafvel-Pursiainen K . Reduced Fhit protein expression in human malignant mesothelioma. Virchows Archiv 2004; 444: 43\u201348.","journal-title":"Virchows Archiv"},{"key":"BFcgt201657_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/JTO.0000000000000493","volume":"10","author":"A Miyanaga","year":"2015","unstructured":"Miyanaga A, Masuda M, Tsuta K, Kawasaki K, Nakamura Y, Sakuma T et al. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol 2015; 10: 844\u2013851.","journal-title":"J Thorac Oncol"},{"key":"BFcgt201657_CR33","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1038\/sj.onc.1209587","volume":"25","author":"P Poulikakos","year":"2006","unstructured":"Poulikakos P, Xiao G, Gallagher R, Jablonski S, Jhanwar S, Testa JR . Re-expression of the tumor suppressor NF2\/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. Oncogene 2006; 25: 5960\u20135968.","journal-title":"Oncogene"},{"key":"BFcgt201657_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/0008-5472.CAN-10-2164","volume":"71","author":"H Murakami","year":"2011","unstructured":"Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T et al. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res 2011; 71: 873\u2013883.","journal-title":"Cancer Res"},{"key":"BFcgt201657_CR35","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-08-4523","volume":"69","author":"G Pinton","year":"2009","unstructured":"Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA et al. Estrogen receptor-\u03b2 affects the prognosis of human malignant mesothelioma. Cancer Res 2009; 69: 4598\u20134604.","journal-title":"Cancer Res"},{"key":"BFcgt201657_CR36","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.bbrc.2006.02.084","volume":"342","author":"S Batra","year":"2006","unstructured":"Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I et al. Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun 2006; 342: 1228\u20131232.","journal-title":"Biochem Biophys Res Commun"}],"updated-by":[{"DOI":"10.1038\/s41388-026-04004-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000}}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201657","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:53:17Z","timestamp":1791442397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,18]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFcgt201657"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2016.57","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,18]]},"assertion":[{"value":"3 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-026-04004-3","URL":"https:\/\/doi.org\/10.1038\/s41388-026-04004-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}